Krause Amanda Jayne, Patel Naiya Balubhai, Morgan Jennifer
Internal Medicine, McGaw Medical Center of Northwestern University, Chicago, Illinois, USA.
BMJ Case Rep. 2019 Sep 18;12(9):e230865. doi: 10.1136/bcr-2019-230865.
ACE inhibitors (ACEi) are common anti-hypertensive drugs that can cause angioedema. Though classic, or facial angioedema is rare, visceral angioedema is even less common. When angioedema occurs, it typically presents early, within 30 days of initiating therapy. Visceral angioedema most commonly presents with nausea, emesis, abdominal pain and diarrhoea, and thus is often mistaken for an episode of gastroenteritis. When a CT scan is obtained, it typically shows characteristic findings, including ascetic fluid, mild mesenteric oedema and thickening of the small bowel. In this case report, we present a patient who did not experience her first episode of visceral angioedema until after she had been on ACEi therapy for 5-7 years. In addition, she experienced recurrent episodes of visceral angioedema that were separated by approximately 4 years at a time. Both of these features make for a particularly unique presentation.
血管紧张素转换酶抑制剂(ACEi)是常见的抗高血压药物,可引起血管性水肿。虽然典型的或面部血管性水肿很少见,但内脏血管性水肿更为罕见。血管性水肿发生时,通常在治疗开始后30天内早期出现。内脏血管性水肿最常见的表现为恶心、呕吐、腹痛和腹泻,因此常被误诊为胃肠炎发作。进行CT扫描时,通常会显示特征性表现,包括腹水、轻度肠系膜水肿和小肠增厚。在本病例报告中,我们介绍了一名患者,她在接受ACEi治疗5至7年后才首次出现内脏血管性水肿。此外,她还经历了反复发作的内脏血管性水肿,每次发作间隔约4年。这两个特征构成了一种特别独特的表现。